Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1100_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Preface
- •Contents
- •Contributors
- •Part I
- •Esophageal Surgery
- •Tracheo-Esophageal Fistula
- •Overview
- •Etiology
- •Clinical Presentation
- •Diagnosis
- •Management
- •Conservative Management
- •Endoscopic Management
- •Operative Management
- •Postesophagectomy TEF
- •Postintubation TEF
- •Bronchoesophageal Fistula
- •Prevention of Tracheoesophageal Fistula
- •Outcomes
- •Conclusion
- •Five Key Points to Avoid Complications
- •Five Key Points to Diagnose or Manage Complications Intra or Postoperatively
- •References
- •Esophageal Strictures Refractory to Endoscopic Dilatation
- •Introduction
- •Etiology of Esophageal Strictures
- •Treatment
- •Treatment of Benign Esophageal Strictures
- •Nonsurgical Options
- •Endoscopic Dilatation
- •Steroid Injection
- •Esophageal Stenting
- •Rendez-Vous Procedure
- •Incisional Therapy
- •Surgical Options
- •Antireflux Surgery for Peptic Strictures
- •Esophagectomy
- •Malignant Esophageal Strictures
- •Endoscopic Treatment
- •Dilatation
- •Stent Placement
- •Laser Therapy
- •Brachytherapy
- •Chemotherapy and Radiation Therapy
- •Surgical Treatment
- •Conclusion
- •Key Points for Avoiding Postsurgical Esophageal Strictures
- •Key Points for Managing Esophageal Strictures
- •References
- •Esophageal Anastomotic Leak
- •Introduction
- •Risk Factors for Anastomotic Leak
- •Presentation and Identification of a Leak
- •Prevention and Management of Anastomotic Leaks
- •Future Directions
- •Conclusion
- •Key Points on Avoiding an Esophageal Anastomotic Leak
- •Key Points on Diagnosis and Managing an Esophageal Anastomotic Leak
- •References
- •Transhiatal Esophagectomy—Intraoperative Disasters
- •Introduction
- •Preoperative Risk Factors for Bleeding with a THE
- •General Considerations
- •Anesthetic Considerations
- •Conduct of the Operation
- •Bleeding Scenarios During THE
- •Tracheal Tear
- •Summary
- •Key Points: Avoiding Catastrophic Complications—Mediastinal Bleeding and Airway Injury—During Transhiatal Esophagectomy
- •Key Points: Diagnosing and Managing Catastrophic Complications—Mediastinal Bleeding and Airway Injury—During Transhiatal Esophagectomy
- •References
- •Chyle Leak After Esophageal Surgery
- •Introduction
- •Historical Review
- •Basic Science
- •Embryology
- •Anatomy
- •Physiology
- •Composition of Chyle
- •Chylothorax
- •Etiology/Cause
- •Post-esophagectomy Chylothorax
- •Diagnosis
- •Clinical Features
- •Fluid Studies
- •Imaging
- •Treatment
- •Conservative Management
- •Surgical Management
- •Summary
- •Key Points on Avoiding an Esophageal Anastomotic Leak
- •Key Points on Diagnosis and Managing an Esophageal Anastomotic Leak
- •References
- •Evaluation of the Vocal Cords
- •Treatment of Unilateral Vocal Cord Dysfunction
- •Injection Augmentation
- •Framework Surgery for Unilateral Vocal Cord Dysfunction
- •Treatment of Bilateral Vocal Paralysis
- •Key Summary Points
- •References
- •Introduction
- •Pathophysiology
- •Classification
- •Symptoms
- •Diagnosis
- •Management of Airway, Hoarseness, and Vocal Cord Dysfunction After Esophagectomy
- •Introduction
- •Vocal Fold Dysfunction
- •Symptoms of Unilateral Vocal Cord Dysfunction
- •Symptoms of Bilateral Vocal Cord Dysfunction
- •Treatment
- •Complications
- •Conclusion
- •Five Key Points on How to Avoid Complications
- •Five Key Points on Diagnosing and/or Managing the Complications Either Intraoperatively or Postoperatively
- •References
- •Intraoperative Solutions for the Gastric Conduit that Will Not Reach
- •Colon as an Alternative Conduit
- •Jejunum as an Alternative Conduit
- •Pedicled Jejunal Interposition
- •Free Jejunal Interposition
- •Summary
- •Key Points
- •References
- •Injury to the Right Gastroepiploic Artery
- •Introduction
- •Anatomy of the RGEA
- •Vascular Considerations in Esophagectomy
- •Preoperative Evaluation of the RGEA
- •Preparation and Mobilization of the Gastric Conduit
- •Techniques for Improving Tissue Oxygenation
- •Tension-Free Anastomosis
- •“Supercharging”
- •Venous Drainage
- •Conclusion
- •Five Key Points: Avoiding Injury to the Right Gastroepiploic Artery
- •References
- •Intra-Operative Solutions for Ischemic Gastric Conduit
- •Gastric Esophageal Replacement Conduit
- •Diagnosis of Gastric Conduit Ischemia
- •Summary
- •Key Points for Avoiding Gastric Conduit Necrosis
- •Key Points for Managing Gastric Conduit Necrosis Postoperatively
- •References
- •Jejunal Feeding Tube Complications
- •Introduction
- •Technique for Placement
- •Open Surgical Jejunostomy Tubes
- •Laparoscopic Jejunostomy Tubes
- •Complications
- •Bowel Necrosis
- •Bowel Obstruction
- •Tube Dysfunction
- •Infectious Complications
- •Aspiration
- •Conclusion
- •Key Points
- •References
- •Part II
- •Gastric Surgery
- •Gastroparesis
- •Etiology
- •Clinical Presentation and Evaluation
- •Management
- •Bile Reflux
- •Etiology
- •Clinical Presentation and Evaluation
- •Management
- •Conclusion
- •Key Points (Prevention)
- •Key Points (Management)
- •References
- •Dealing with Dumping Syndrome
- •Introduction
- •Diagnosis
- •Prevention
- •Management of Dumping Syndrome
- •Diet
- •Pharmacologic Therapy
- •Acarbose
- •Somatostatin Analogs
- •Studies of the Fast-Acting Somatostatin Analog Octreotide
- •Studies of Long-Acting Octreotide LAR
- •Adverse Effects of Somatostatin Analogs
- •Surgical Treatment
- •Conversion of Billroth II to Billroth I Anastomosis
- •Roux-en-Y Conversion
- •Continuous Enteral Feeding
- •Conclusion
- •Key Points
- •References
- •Introduction
- •Epidemiology
- •Etiology
- •Pathophysiology
- •Clinical History
- •Physical Findings
- •Differential Diagnosis
- •Diagnosis
- •Noninvasive Imaging Studies
- •Treatment
- •Medical Treatment
- •Endoscopic/Interventional Radiology
- •Surgical Intervention
- •Summary
- •Key Points for Avoiding
- •Key Points for Diagnosing/Managing
- •References
- •Duodenal Stump Blowout
- •Introduction
- •Clinical Presentation of Blowout
- •Mechanisms Contributing to Blowout
- •Staple Line Failure
- •Distal Obstruction
- •Malnutrition
- •The Difficult Duodenum
- •Techniques for Reducing the Risk of Blowout
- •Management of the Difficult Duodenum
- •General Principles of Closure
- •Nissen Technique
- •Bancroft Technique
- •Tube Duodenostomy and Drainage
- •Management of Stump Blowout
- •Medical Management
- •Percutaneous Radiologic Techniques
- •The Decision to Operate and Surgical Approach
- •Summary of Management
- •Ramifications of Blowout
- •Conclusions
- •Key Points: Avoiding Duodenal Stump Blowout
- •Key Points: Diagnosing and Managing Stump Blowout
- •References
- •Postoperative Complications After Surgery for Gastric Cancer: Anastomotic Leakage
- •Introduction
- •Incidence
- •Prospective Factors
- •Detection
- •Differential Diagnosis
- •General Management
- •External Drainage
- •Treatment of the Leakage Site
- •Duodenal Stump Leakage
- •Summary
- •Five Key Points to Avoid Anastomotic Leakage
- •Five Key Points to Diagnose and Manage Leakage
- •References
- •Part III
- •Hepatobiliary and Pancreatic Surgery
- •Introduction
- •Definition of PHI
- •Risk Factors for PHI
- •Prevention of PHI
- •Systematic Volumetry of the “Fully Functioning” Part of the Liver
- •Portal Vein Embolization
- •Limiting the Duration of Preoperative Chemotherapy
- •Treatment of PHI
- •Conclusion
- •Key Points
- •References
- •Biliary Leaks and Thoracobiliary Fistula
- •Introduction
- •Definitions
- •Biliary Leak and Grading System
- •Controlled and Uncontrolled Biliary Leaks
- •Source
- •Risk Factors and Prevention
- •Prevention
- •Risk Factors for Bile Leaks After Extrahepatic Bilioenteric Anastomosis
- •Prevention
- •Risk Factors for Bile Leak After Liver Resection
- •Prevention of Biliary Leaks After Hepatectomy
- •Intraoperative Tests for Bile Leaks
- •Postoperative Drains
- •Diagnosis
- •Investigations
- •Ultrasonography or CT Scan
- •Fistulogram
- •MRC, ERC, and PTC
- •HIDA
- •Management
- •Medical Management
- •Endoscopic Management
- •Interventional Radiology
- •Combined Endoscopic and Interventional Radiology Approaches—Rendezvous Procedures
- •Thoracobiliary Fistula
- •Diagnosis
- •Treatment
- •Five Key Points to Avoid Complications
- •Five Key Points to Diagnosis or Manage Complications
- •References
- •Contralateral Bile Duct Injury During Hepatic Resection
- •Introduction
- •Etiology and Risk Factors
- •Anatomical Variations
- •Difficult Surgical Resection and Reoperation
- •Type of Liver Resection
- •Aggressive Dissection and Devascularization of Bile Ducts
- •Initial Investigations and Management
- •Initial Investigations
- •Stabilization and Operative Planning
- •No Evidence of Distal Obstruction with Fistula
- •Evidence of Distal Obstruction with Fistula
- •Evidence of Distal Obstruction but no Fistula
- •Definitive Management
- •Anatomy Relevant to Operative Repair of Biliary Outflow of Remnant
- •Operative Repair
- •Repair of Injury to Right Liver Outflow
- •Repair of Injury to Left Liver Outflow
- •Prevention of Contralateral Bile Duct Injury
- •Attention to Variation in Biliary
- •Intrahepatic Control of Biliary Radicals
- •Tumor Close to the Hilum
- •Outcomes
- •Five Key Points to Avoid Contralateral Bile Duct Injury
- •Five Key Points to Diagnose and Treat Contralateral Bile Duct Injury
- •References
- •Massive Intraoperative Hemorrhage During Hepato-Biliary and Pancreatic Surgery
- •Introduction
- •Hemorrhage During Liver Surgery
- •Magnitude of Problem
- •Hepatic Vascular Anatomy
- •Prevention of Major Hemorrhage During Hepatic Resection
- •Techniques Aimed at Reducing Blood Loss During Hepatic Surgery
- •Deliberate Dissection and Exposure of Retro-Hepatic Vena Cava and Major Hepatic Veins
- •Hepatic Inflow Control
- •Vascular Isolation
- •Acute Normovolemic Hemodilution (ANH)
- •Management of Intra-Operating Bleeding During Liver Resection
- •Massive Hemorrhage During Pancreatic Surgery
- •Pancreatic Anatomy
- •Bleeding During Pancreaticoduodenectomy
- •Summary
- •5 Key Points to Avoid Complications
- •References
- •Intraoperative Injury to Hepatic Arterial Structures
- •Introduction
- •Normal Anatomy of the Hepatic Arterial Vasculature
- •Variant Anatomy of the Hepatic Arterial Vasculature
- •Replaced and Accessory Right Hepatic Arteries
- •Replaced and Accessory Left Hepatic Arteries
- •Replaced Common Hepatic Artery
- •Celiac Artery Stenosis
- •Preoperative Radiographic Assessment
- •Preoperative Considerations
- •Intraoperative Considerations
- •Specific Intraoperative Considerations
- •Pancreaticoduodenectomy (PD)
- •Replaced/Accessory Right Hepatic Artery
- •Replaced Common Hepatic Artery
- •Celiac Artery Stenosis
- •Hemi-hepatectomy
- •Conclusions
- •Key Points: Preoperative Interventions
- •Key Points: Intraoperative Principles
- •References
- •Hepatic Abscess
- •Etiology
- •Diagnosis
- •Computed Tomography
- •Ultrasound
- •Magnetic Resonance Imaging
- •Treatment
- •Five Key Points on How to Avoid Complications
- •Five Separate Key Points on Diagnosing and/or Managing the Complication
- •References
- •Hepaticojejunostomy Anastomotic Strictures
- •Introduction
- •Diagnosis
- •Clinical and Biological Presentation
- •Morphological Evaluation
- •Incidence and Risk Factors According to the Clinical Context
- •Iatrogenic Bile Duct Injury
- •Liver Transplantation (LT)
- •Pancreatic Head Resection
- •Choledochal Cyst
- •Therapeutic Options
- •Conservative Management
- •Choice of the Approach
- •To Stent or Not to Stent?
- •Periprocedural Management
- •Surgery
- •Revisionary Surgery
- •Liver Resection
- •Liver Transplantation (LT)
- •Key Points: How to Avoid HJ Stricture
- •Key Points: Diagnostic and Management
- •References
- •Defining Pancreatico-Jejunostomy Strictures (PJS) and Pancreatico-Jejunostomy Strictures (PGS) by Symptoms, Morphology and Function
- •Management of Intractable Pain Due to PJA or PGS Stenosis in Surgical Case Series
- •Endoscopic Techniques for Management of PJA Strictures
- •Technical Clinical Results for ERP
- •EUS-Guided Access and Drainage
- •EUS-Guided Rendezvous
- •Pancreatic Antegrade Needle Knife (PANK) Technique
- •EUS-Guided Pancreatogastrostomy
- •Jejunal Stenosis Mimicking PJA Stenosis
- •Conclusions
- •Key Points
- •References
- •Postoperative Portal, Mesenteric, and Splenic Vein Thrombosis
- •Introduction
- •Pathophysiology
- •Diagnosis: Clinical Manifestations and Blood Tests
- •Diagnosis: Imaging Tests
- •Treatment
- •Anticoagulation
- •Interventional Techniques
- •Surgery
- •Conclusion
- •Key Points for Diagnosis
- •Key Points for Treatment
- •References
- •Postpancreatectomy Hemorrhage: Early and Late
- •Introduction
- •Prevention of Late PPH
- •The Falciform Ligament
- •The Portal Dissection
- •GDA Ligation
- •Reinforcing the Pancreatic Transection Site (Distal Pancreatectomy)
- •Diagnosis of Late PPH
- •Symptoms/Signs
- •Imaging for Late PPH
- •Management of PPH
- •Early PPH
- •Late PPH
- •Conclusion
- •Key Points to Avoid Complications
- •Key Points to Diagnose/Manage
- •References
- •Major Disruptions of Pancreaticojejunostomy
- •Introduction
- •Conclusion
- •Key Points: How to Avoid Complications
- •Key Points: Diagnosis/Management
- •References
- •Persistent Pancreatic Fistula
- •Introduction
- •Definition of Pancreatic Fistula
- •Procedure-Specific Incidence and Risk Factors for Pancreatic Fistula
- •Pancreaticoduodenectomy
- •Distal Pancretectomy
- •Duodenum-Preserving Pancreatic Head Resection/Lateral Pancreaticojejunostomy
- •Pancreatic Pseudocyst Drainage/Pancreatic Necrosectomy
- •Other Pancreatic Resections
- •Prevention of Pancreatic Fistula
- •Complications of Pancreatic Fistula
- •Management of Pancreatic Fistula
- •Initial Management
- •Delineation of Pancreatic Duct
- •Definitive Treatment of Pancreatic Fistula
- •Operative Management of Pancreatic Fistula
- •Conclusion
- •Key Points to Avoid Complications
- •Key Points: Diagnosing and/or Managing Complications Either Intra- or Postoperatively
- •References
- •Management of Chyle Leaks Following Pancreatic Resection
- •Introduction
- •Background
- •Anatomy and Physiology of Visceral Lymphatics
- •Diagnosis of a Chyle Leak
- •Management of a Chyle Leak
- •The Contained Chyle Leak
- •Chylous Ascites
- •Management of Refractory Chyle Leaks
- •Conclusion
- •Key Points in Managing a Chyle Leak
- •References
- •Overview
- •Diagnosis
- •Prevention
- •Identifying Risk Factors
- •Role of Octreotide
- •Role of Pancreatic Stenting
- •Dissection and Management of the Pancreatic Stump
- •Minimally Invasive Versus Open Techniques
- •Drain Placement and Management
- •Management of Complications of Pancreatic Leak
- •Goal-Directed Resuscitation and Infection Control
- •Further Definition of Anatomy and Source Control
- •Optimizing Patient Clinical Status for Ongoing Conservative Management
- •Deliberate Reintervention When Clinically Indicated
- •Summary
- •Key Points on Avoiding Complications
- •Key Points on Diagnosis/Management of Complications
- •References
- •Part IV
- •Colorectal Surgery
- •Pearls for the Small Bowel and Colon That Will Not Reach
- •Introduction
- •Anatomic Constraints
- •Diagnosing the Problem
- •Specific Techniques: Making It Reach
- •Colorectal and Coloanal Anastomosis
- •Lateral-to-Medial Approach
- •Medial-to-Lateral Approach
- •Ileal-Pouch Anal Anastomosis (IPAA)
- •Stomas that Do Not Reach
- •Bailout Maneuvers—It Just Does Not Reach
- •Conclusions
- •Key Points on How to Avoid the Complication
- •Key Points on Diagnosing/Managing the Complication
- •References
- •Anastomotic Leak/Pelvic Abscess
- •Introduction
- •Prevention
- •Diagnosis and Management
- •Diagnosis
- •Management
- •Type I: Generalized Peritonitis
- •Type II: Localized Pelvic Abscess
- •Type III: Fistula
- •Long-Term Outcome
- •Need for a Permanent Stoma
- •Stenosis or Stricture
- •Local Recurrence
- •References
- •Management of Anastomotic Stricture
- •Introduction
- •Etiology of Anastomotic Stricture
- •Presentation and Diagnosis
- •Nonoperative Treatment
- •Balloon Dilation and Endoscopic Options
- •Stents
- •Operative Treatment
- •Reoperative Surgery
- •Anastomotic Revision and Diverting Stomas
- •New Technology
- •Conclusion
- •To Avoid Anastomotic Strictures in Colorectal Resections
- •Five Points on Diagnosing and Managing Anastomotic Strictures
- •References
- •Intraoperative Ureteral Injury
- •Introduction
- •Role of Preoperative Stenting
- •Incidence of Ureteric Injury and Early Identification of Injury
- •Placement of Ureteral Stents
- •Detection of Ureter Injury
- •Management of Ureter Injury
- •Proximal Third Injuries
- •Middle Third Ureteral Injuries
- •Lower Third Ureteral Injuries
- •Delayed Ureteral Transection or Ligation
- •Management Post Repair
- •Outcomes
- •Key Points to Avoiding Injury
- •Key Points to Diagnosis and Manage the Complication
- •References
- •Introduction
- •Anatomy
- •Incidence
- •Types of Prostatic Urethral Injury
- •Prevention
- •Detection
- •Management
- •Delayed Rectourethral Fistula
- •Conclusion
- •Key Points on Avoiding Complications
- •Key Points on Diagnosing/Managing Prostatic Urethral Injuries
- •References
- •Vaginal Injury During Stapled Anastomosis
- •Introduction
- •How to Avoid Vaginal Injury
- •How to Fix Vaginal Injury
- •Key Points on How to Avoid Vaginal Injury
- •Management of Rectovaginal Fistula
- •Introduction
- •General Principles
- •Local Repair
- •Mucosal Advancement Flap Repair
- •Endorectal Advancement Flap with Muscular Plication (Anterior Levatorplasty)
- •Transanal Sleeve Advancement Flap
- •Transvaginal Repair
- •Fistulotomy
- •Ligation of Intersphincteric FistulaTract
- •Biological Agents: Fibrin Glue and Fistula Plug
- •Miscellaneous
- •Tissue Transfer Procedures
- •Gracilis Muscle Interposition Flap
- •Martius Flap
- •Abdominal Procedure
- •Transperineal Omental Flap
- •Perioperative Management
- •Conclusion
- •Key Points to Avoid Complications
- •Key Points on Diagnosis and/or Managing Complications
- •References
- •Management of Presacral/Pelvic Bleeding
- •Introduction
- •Anatomy
- •Patterns of Injury
- •Management
- •Role of the Anaesthesiologist
- •Role of the Surgeon
- •Minimal-Access Surgery
- •The Postoperative Period
- •Summary
- •Key Points
- •References
- •Introduction
- •Preoperative Evaluation
- •Medical Comorbidities
- •Radiation Therapy
- •Chemotherapy
- •Imaging
- •Timing of Reconstruction
- •Classification of Defect
- •Reconstructive Surgical Tenants
- •Adjuncts to Flap Surgery
- •Negative Pressure Wound Therapy
- •Tissue Expansion
- •Biologic Tissue Matrices
- •Rectus Abdominis Muscle
- •Gracilis Muscle Flap
- •Gluteus Maximus Muscle
- •Pudendal Flap
- •Anteriolateral Thigh Flap
- •Postoperative Care
- •Ambulation
- •Drain Management
- •Complications
- •Summary
- •Key Points: Preventing Complications
- •Key Points: Managing Complications
- •References
- •Complications After TEM (Transanal Endoscopic Microsurgery) and TAMIS (Transanal Minimally Invasive Surgery)
- •Background
- •Complications of TEM and TAMIS
- •Postoperative Fever
- •Wound Dehiscence
- •Rectal Pain
- •Peritoneal Perforation
- •Pelvic Phlegmon and Abscess
- •Fistula
- •Bleeding
- •Incontinence
- •Conclusion
- •Key Points: Avoiding a Complication
- •Key Points: Managing/Diagnosing Septic Complications
- •References
- •Parastomal Hernia
- •Overview
- •Definition and Classification
- •Incidence
- •Pathophysiology
- •Risk Factors
- •Complications
- •Prevention
- •Preoperative Considerations
- •Operative Considerations
- •Diagnosis
- •History and Physical Exam
- •Imaging
- •Management
- •Nonoperative Management
- •Operative Management
- •Open Approach
- •Laparoscopic Approach
- •Postoperative Complications
- •Management of Recurrent Parastomal Hernias
- •Key Points: Diagnosing/Managing Parastomal Hernia
- •Key Points: Avoiding Parastomal Hernia Complications
- •References
- •Stoma Retraction/Ischemia/Stenosis
- •Introduction
- •Etiology/Incidence/Risk Factors
- •Prevention
- •Recognition/Assessment/Severity/Therapy
- •Conclusions
- •Five Keys Points in Diagnosing and Managing Stenosis, Retraction, and Ischemia in an Ostomy
- •Five Key Points on How to Avoid Tension and Ischemia in an Ostomy
- •References
- •Incontinence After Lateral Internal Sphincterotomy/Fistulotomy
- •Introduction
- •Lateral Internal Sphincterotomy
- •Fistulotomy
- •Management
- •Evaluation
- •Treatment
- •Injectables
- •Magnetic Bowel Sphincter
- •Sacral Nerve Stimulator
- •Artificial Bowel Sphincter
- •Diversion
- •Key Points: Strategies to Avoid the Complication of Incontinence
- •Key Points: Diagnosing and/or Managing the Complication of Incontinence Either Intraoperatively or Postoperatively
- •References
- •Anal Stenosis After Hemorrhoidectomy: Avoidance and Management
- •Introduction
- •Diagnosis
- •Classification of Stenosis
- •Treatment
- •Prevention
- •Nonoperative Intervention
- •Operative Intervention
- •Anatomic Versus Functional Stenoses
- •Preoperative Planning
- •Postoperative Care
- •Summary
- •Key Points: Managing Complications
- •References
- •Part V
- •Other Considerations
- •Delivering Bad News: Conversations with My Surgeon
- •Introduction
- •Informed Consent
- •The Family Does Not Want the Patient to be Fully Informed
- •Perioperative Death
- •When an Intraoperative Death Does Occur
- •Discussion of Unresectability or Metastatic Disease that Precludes Resection
- •Discussion of a Postoperative Complication
- •Discussion of the Unanticipated Major Postoperative Complication
- •Discussion of Operative Findings
- •The Need for Reoperation
- •Complications that Occur in your Absence from the Hospital
- •Withdrawal of Life-Sustaining Measures
- •Discussing the Pathology Report
- •Discussion of Long-term Survival Prospect
- •Management of the Difficult Family
- •References
- •Index

276 A. Amini et al.
site. It implies the presence of a structural vascular defect and requires immediate evaluation
[23]. Sentinel hemorrhage, as mentioned previously, is often associated with local sepsis and an
anastomotic leak; it is uncommon to see late PPH
in a patient who has had a completely uneventful
postoperative course [24]. Patients who develop
a sentinel bleed, as defined as a low volume of
hemorrhage in a patient who is hemodynamically
stable at the time of the event, are at high risk
of developing massive hemorrhage and should
undergo diagnostic and therapeutic intervention
as soon as possible [7, 8, 16]. The second episode of bleeding may follow in minutes or hours
and is often severe, being accompanied by hemodynamic instability and a high risk of mortality.
Vigilance is critically important, as up to 90 % of
patients who experience PPH have been through
a turbulent postoperative period characterized by
some form of intra-abdominal infection. Those
patients who have had conservative management
or radiological interventions for intra-abdominal
fluid collections are at particularly high risk, and
therefore, a sentinel hemorrhage in this setting
warrants immediate attention [7, 16].
Imaging for Late PPH
Management of the exsanguinating patient with
late PPH is unlikely to be successful and therein lies the rationale for immediate action in the
setting of a sentinel bleed. A patient presenting
with a sentinel bleed should undergo immediate
angiography. If the diagnosis of a sentinel bleed
is less clear, for example, the blood in the drain
may have been associated with accidental traction on the drain, or the issue of a possible melanotic stool is in question, then CT imaging prior
to angiography is quite reasonable. Ultrasound
imaging may depict a false aneurysm but has no
role in the investigation of acute bleeding. CT angiography may reveal the cause, site, and nature
of bleeding if contrast extravasation is seen or
a pseudo-aneurysm is visualized. A triple-phase
examination (unenhanced, arterial, and venous
phases) is performed with iodinated contrast
material. Images are reviewed with multiplanar
reformatting, which contributes to the diagnosis and aids in the planning of endovascular or
surgical intervention. Unenhanced scans depict
collections and high attenuation from beam-hardening and streak artifacts that can mimic bleeding. The arterial phase may reveal active contrast
extravasation from the arterial anatomy. The venous phase may show contrast pooling and other
complications that can follow a Whipple procedure [25, 26].
If CT imaging does not yield a focus for the
bleeding and the patient becomes unstable or an
unequivocal sentinel bleed were to occur, the patient should move directly to selective angiography without delay. Caution should be taken in interpreting the results of angiography if a bleeding
site is not seen, as a negative examination does
not rule out a late PPH. The intermittent nature
of the bleeding can hamper detection by angiography even in patients with severe stigmata of
bleeding. The importance of angiography cannot be overstated: first, embolization can be performed if the bleeding site is located and second,
the alternative treatment to consist of reoperation is unlikely to be successful [27]. Emergent
reoperative laparotomy in an effort to expose
the GDA stump in an unstable patient stands a
very low likelihood of being successful even if
performed by a very experienced surgeon. The
main (and perhaps only) hope for a good patient
outcome rests in the interventional radiology
suite, not the operating room. If the site of bleeding is uncertain, angiography of the celiac axis
and SMA should be performed. Active contrast
extravasation and pseudoaneurysms can be managed therapeutically when the diagnosis is made.
Spasm and irregularity of a vessel are indirect
signs of a source of bleeding. If extravasation
from the expected sites is not seen, selective/superselective angiography can be performed [27].
Management of PPH
Early PPH
Management of early PPH should consist of resuscitation and in general, emergent return to

27726 Postpancreatectomy Hemorrhage: Early and Late
the operating room for laparotomy. Very rarely,
gastrointestinal hemorrhage early in the postoperative period can be managed endoscopically.
Therapeutic endoscopy may permit the successful management of a bleeding point in the gastrojejunostomy, which would be the only indication
for endoscopy early in the postoperative setting.
However, the pancreaticojejunostomy would be
more likely to be the source of hemorrhage rather
than the gastrojejunostomy. Patients with intraabdominal bleeding, whether evident from a surgically placed drain or due to progressive expansion of the abdomen on examination, require reoperation, and a delay should not occur [12–14].
Late PPH
Patients with late PPH should undergo emergent
selective angiography and if the source is found,
embolization of the bleeding vessel should be
performed. Embolization is successful in up to
80 % of patients although this complication is
uncommon and reports are largely anecdotal or
consist of small series from large referral institutions. As noted previously, the key to preventing mortality is rapid recognition and prompt
management. Postoperative gastrointestinal or
drain tract bleeding should prompt immediate
evaluation with arteriography. Gastrointestinal
or drain tract bleeding represents a true medical
emergency as the only patients likely to survive
are those in whom the diagnosis is made immediately. Although individual surgeon experience
with this complication is largely anecdotal, stenting of the hepatic artery or the more conventional
embolization of the hepatic artery may both be
successful. In the setting of a normal bilirubin,
the liver will usually tolerate hepatic artery embolization when it is performed a few weeks after
the hepaticojejunostomy. Multisystem organ
failure and death usually result from the infectious complications and the excessive blood loss
which may accompany/often accompanies this
complication [22].
Embolization sacrifices distal blood flow but
is the only alternative for areas where anatomy is
complex and vessels are small [27]. The embol-
ic materials used are coils, glue, thrombin, and
absorbable gelatin sponge. Coils are commonly
used and suitable when there is a single feeding
vessel which can be sacrificed. It is essential to
embolize both the inflow and outflow vessels or
bleeding may recur. Balloon occlusion can be
used for protection of distal circulation but tissue infarction is more likely than with coils. Stent
grafting preserves distal perfusion, such as that
to the liver and spleen, but can be impossible in
tortuous and small vessels. Intentional dissection
is an option if the bleeding site cannot be reached
selectively for embolization [28, 29].
Pseudoaneurysms that persist after embolization can be managed with percutaneous injection
of thrombin under ultrasound or CT guidance
[16, 29]. The GDA stump is the most common
cause of active extravasation or pseudoaneurysm
formation. A bleeding source in the common or
proper hepatic arteries can also occur as the result
of a pancreatic leak. Covered stents are useful
and have the added benefit of preserving distal
perfusion. Celiac axis erosion is uncommon, and
endovascular stent grafting is an option for management although this procedure may involve
sacrificing either the hepatic or the splenic artery.
An alternative is to embolize the whole vessel to
ensure that there is no back filling from the celiac
axis branches [30].
Splenic artery pseudoaneurysm is uncommon
and when it occurs, is once again usually secondary to a pancreatic leak or intraoperative infection. Management depends on the site of extravasation and the tortuosity of the splenic artery. A
covered stent can be used in straight arteries; in
tortuous vessels, embolization is required. Proximal lesions can be embolized with preservation
of splenic perfusion via the short gastric arteries
as the left gastric artery is preserved and remains
the main source of gastric perfusion. Embolization of distal lesions increases the risk of splenic
infarction.
IPDA pseudoaneurysms are rarely seen after
the Whipple procedure but when they occur, they
are the result of a local infection (pancreatic leak)
or abscess formation adjacent to the SMA. If
bleeding is present, the problem can be managed
with embolization or stenting.

278 A. Amini et al.
Hemobilia due to a hepatic artery pseudoaneurysm with involvement of the residual common
bile/hepatic duct in the inflammatory process can
manifest itself as false extraluminal bleeding.
The hepatic artery can be managed with embolization [29–31].
Conclusion
Complication rates for pancreatectomy still persist due to the large magnitude of the operation
which is usually performed in patients of advanced age with associated comorbidities. PPH
is one of the major causes of morbidity and mortality after PD. PPH can be divided into early and
late postoperative bleeding. Early PPH is that
which occurs within 24
caused by technical failure of appropriate hemostasis during the index operation (failure to perform the SMA dissection correctly and to identify and ligate the IPDAs) or by an underlying
perioperative coagulopathy. Late PPH occurs
more than 24
one or more weeks from the date of surgery. Late
PPH is associated with more common complications of the operation, most notably a leak from
the pancreaticojejunostomy. Local sepsis from
a pancreatic fluid collection or intra-abdominal
abscess may erode the vascular wall adjacent to
a loop of bowel leading to PPH. Prevention of
PPH depends both on careful dissection of the
portahepatis and the hepatic artery/GDA and on
creation of a pedicled falciform ligament flap to
protect the vessels from possible pancreatic fistula and fluid collections. For patients who receive a distal pancreatectomy, reinforcement of
the pancreas transection site with Gore-Tex or
pledgeted sutures can also be followed with falciform ligament flap coverage. The occurrence of
a sentinel bleed is a key sign which often occurs
before the onset of late PPH. Patients who develop a sentinel bleed, especially those who have
had a complicated/septic postoperative period
have a high risk of developing imminent massive
hemorrhage and should undergo immediate diagnostic and therapeutic angiography.
h after the
h of sur
operation and typically
gery. It often is
Management of early PPH depends on whether the bleeding is located intraluminally or extraluminally. Interventional endoscopy is occasionally indicated when intraluminal PPH is suspected to originate from the gastrojejunostomy;
reoperation is usually the treatment of choice
for early PPH and in all cases where the blood is
intra-abdominal (extraluminal). In the case of a
late PPH usually associated with pancreatic fistula formation, angiography is the intervention of
choice and should be performed without delay. If
the source cannot be found at the first attempt at
angiography, re-angiography may be performed
within 6–24
of late PPH is prevention—a carefully performed
operation and use of vascularized tissue to separate the hepatic artery from the afferent jejunal
limb to include careful coverage of the GDA
stump.
h. The best solution
to the problem
Key Points to Avoid Complications
1. Preserve the falciform ligament (obliterated
umbilical vein) for use as coverage of the
GDA stump, vascular anastomoses, or the
splenic artery stump (in the case of a distal
pancreatectomy).
2. When a distal pancreatectomy is performed,
the falciform ligament can be sutured to the
remnant pancreas allowing for complete sepa-
ration of the adjacent vessels from the pancre-
as in the event of a pancreatic fistula.
3. Dissection of the hepatic artery should be per-
formed with gentle, sharp dissection. Blunt
dissection, especially at the GDA origin, can
result in intimal dissection of the hepatic ar-
tery.
4. If the tumor extends to within a few millime-
ters of the GDA origin, our technique is to ob-
tain proximal and distal control of the hepatic
artery and then divide the GDA flush at its ori-
gin.
5. We routinely reinforce our remnant pancreatic
transection with stapled Seamguard (Gore,
Newark, DE) or pledgeted sutures.

27926 Postpancreatectomy Hemorrhage: Early and Late
Key Points to Diagnose/Manage
1. The occurrence of a sentinel bleed is a key
sign, which often signals the onset of a significant PPH.
2. A patient presenting with an obvious sentinel bleed (acute blood loss of gastrointestinal
(hematemesis or melena) or drain-site origin)
should undergo immediate angiography in
search of a pseudoaneurysm.
3. If the presence or absence of a sentinel bleed is
not obvious (trace amount of blood at a drain
site or a drop in hemoglobin in the absence of
hematemesis or melena), a contrast-enhanced
CT scan is indicated.
Patients who are found to have extraluminal
4.
PPH (most commonly the
GDA stump) should
undergo embolization or stent placement.
Splenic artery pseudoaneurysms are
5.
uncommon and most often secondary to a pancreatic
leak or intraoperative trauma.
Disclosures
No funding sources or conflicts
of
interests.
References
1. Crist DW, Sitzmann JV, Cameron JL. Improved hospital morbidity, mortality, and survival after the Whipple
procedure. Ann Surg. 1987;206:358–65.
2. Miedema BW, Sarr MG, van Heerden JA, et al. Complications following pancreaticoduodenectomy. Current management. Arch Surg. 1992;127:945–9.
3. Trede M, Schwall G. The complications of pancreatectomy. Ann Surg. 1988;207:39–47.
4. Balladur P, Christophe M, Tiret E, Parc R. Bleeding of the pancreatic stump following pancreatoduodenectomy for cancer. Hepatogastroenterology.
1996;43:268–70.
5. Yoshida T, Matsumoto T, Morii Y, et al. Delayed massive intraperitoneal hemorrhage after pancreatoduodenectomy. Int Surg. 1998;83:131–5.
6. Otah E, Cushin BJ, Rozenblit GN, et al. Visceral artery
pseudoaneurysms following pancreatoduodenectomy.
Arch Surg. 2002;137:55–9.
7. van Berge Henegouwen MI, Allema JH, van Gulik
TM, et al. Delayed massive haemorrhage after pancreatic and biliary surgery. Br J Surg. 1995;82:1527–31.
8. Brodsky JT, Turnbull AD. Arterial hemorrhage after
pancreatoduodenectomy. The ‘sentinel bleed’. Arch
Surg. 1991;126:1037–40.
9. Rumstadt B, Schwab M, Korth P, et al. Hemorrhage after
1998;227:236–41.
10. Wente MN, V
tomy hemorrhage (PPH): an international study
group of pancreatic surgery (ISGPS) definition. Surgery. 2007;142:20–5.
11.
de Castro SM, Busch OR, Gouma DJ. Management
of bleeding and leakage after pancreatic sur
Pract Res Clin Gastroenterol. 2004;18(5):847–64.
12. Sohn TA,
duodenectomy: role of interventional radiologists in
managing patients and complications. J Gastrointest
Surg. 2003;7:209–19.
13.
Beyer L, Bonmardion
of non-operative therapy for delayed hemorrhage
after pancreaticoduodenectomy. J Gastrointest Surg.
2009;13:922–8.
14.
Standop J, Schäfer N, Overhaus M, et al. Endoscopic
management of anastomotic
creatogastrostomy. Surg Endosc. 2009;23:2005–10.
Yekebas EF,
15.
Postpancreatectomy hemorrhage:
treatment: an analysis in 1669 consecutive pancreatic
resections. Ann Surg. 2007;246(2):269–80.
16. Sato N, Yamaguchi K, Shimizu S, et al. Coil embolization of bleeding visceral pseudoaneurysms following pancreatectomy: the importance of early
angiography. Arch Surg. 1998;133:1099–102.
17. Choi SH, Moon HJ, Heo JS, et al. Delayed hemorrhage after pancreaticoduodenectomy. J Am Coll
Surg. 2004;199:186–91.
18.
Munoz-Bongrand N, Sauvanet A, Denys A, et al.
Conservative management
pancreaticoduodenectomy with pancreaticogastrostomy. J Am Coll Surg. 2004;199:198–203.
19. Shankar S, Russell RC. Haemorrhage in pancreatic
disease. Br J Surg. 1989;76:863–6.
20. Fuks D, Piessen G, Huet E, et al. Life-threatening
postoperative pancreatic fistula (grade C) after pancreaticoduodenectomy: incidence, prognosis, and
risk factors. Am J Surg. 2009;197:702–9.
21. Lee JH, Hwang DW, Lee SY, et al. Clinical features
management of pseudoaneurysmal bleeding after
and
pancreatoduodenectomy. Ann Surg. 2012;78(3):
309–17.
22. Evans DB, Christians KK, Foley W. Pancreaticoduodenectomy (Whipple operation) and total pancreatectomy for cancer. In: Fischer JE, editor. Mastery of
surgery. 6th ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2012. pp. 1445–64.
23. Tien YW, Wu YM, Liu KL, Ho CM, Lee PH.
Angiography is indicated for every sentinel bleed
after pancreaticoduodenectomy. Ann Surg Oncol.
2008;15:1855–61.
24. Tsirlis T
atic leak related hemorrhage following pancreaticoduodenectomy a case series. JOP. 2009;10:492–5.
pancreatoduodenectomy. Ann Surg.
eit JA, Bassi C, et
Yeo CJ, Cameron JL, et
R, Marciano S, et
Wolfram L, Cataldegirmen G, et
, Vasiliades G, Koliopanos A, et
al. Postpancreatec-
al. Pancreatico-
hemorrhage from pan-
diagnosis and
of pancreatic fistula after
gery. Best
al. Results
al.
al. Pancre-

280 A. Amini et al.
25. Smith SL, Hampson F, Duxbury M, Rae DM, Sinclair
MT. Computed tomography after radical pancreaticoduodenectomy (Whipple’s procedure). Clin Radiol.
2008;63:921–8.
26.
Lepanto L, Gianfelice D, Déry R, et al. Postoperative
changes, complications, and recurrent disease after
Whipple’s operation: CT features. AJR Am J Roentgenol. 1994;163:841–6.
27.
Makowiec F, Riediger H, Euringer W
agement
pancreatic head resection. J Gastrointest Surg.
2005;9:1293–9.
28.
Kaw LL Jr, Saeed
RB. Use of a stent graft for bleeding hepatic artery
pseudo aneurysm following pancreaticoduodenectomy. Asian J Surg. 2006;29:283–6.
of delayed visceral arterial bleeding after
M, Brunson M, Delaria GA, Dilley
, et
al. Man-
29.
Wallace MJ, Choi E, McRae
mesenteric artery pseudoaneurysm following pan
creaticoduodenectomy: management by endovascular stent-graft placement and transluminal
thrombin injection. Cardiovasc Intervent Radiol.
2007;30:518–22.
30. Puppala S, Patel J, McPherson S, Nicholson A, Kessel D. Hemorrhagic complications after Whipple surgery: imaging and radiologic intervention. AJR Am J
Roentgenol. 2011;196(1):192–7.
31.
Otah E, Cushin
pseudoaneurysms following pancreatoduode-
artery
nectomy. Arch Surg. 2002;137:55–9.
BJ, Rozenblit GN, et
S, et
al. Superior
al. Visceral
-

Major Disruptions of Pancreaticojejunostomy
Jonathan C. King, Melissa Hogg and Herbert J. Zeh
27
Introduction
Modern series of pancreaticoduodenectomy
(PD) operations consistently report mortality of
well under 5 % and morbidity of 30–50 % in selected high-volume centers [1]. These outcomes
are possible as a result of advances in surgical
technique as well as in the perioperative care of
patients who are more complex and have greater
comorbidity than patients undergoing PD in prior
eras. Patient selection and preparation are essential in order to maximize the potential for good
outcomes. Wolfgang et al. have examined predictors of mortality following PD in over 1500
cases. They found that age, male sex, preoperative albumin, tumor size, and total pancreatectomy predicted 30-day mortality [2]. Of these factors, preoperative nutrition is the only modifiable
risk factor.
Preoperative malnutrition and micronutrient
deficiency may be severe in patients with pancreatic or periampullary malignancy, particularly
H. J. Zeh ()
Division of Surgical Oncology, UPMC Cancer Pavilion,
Suite 417, 5150 Center Ave, Pittsburgh, PA 15232, USA
e-mail: zehxhx@upmc.edu
J. C. King · M. Hogg · H. J. Zeh
Department of Surgery, University of Pittsburgh Medical
Center, Pittsburgh, PA, USA
e-mail: kingjc@upmc.edu
M. Hogg
e-mail: hoggme@upmc.edu
in the setting of biliary obstruction, which may
lead to significant deficiencies in fat-soluble
vitamins A, D, E, and K. Careful assessment of
preoperative weight loss, difficulties with alimentation (i.e., anorexia, early satiety, gastric
outlet obstruction, and steatorrhea), and duration of jaundice aid in identifying patients with
significant malnutrition who are at risk for major
perioperative complications. Preoperative biliary decompression is often a consideration and
should be generally avoided if definitive operation is planned within 7–10 days [3]. For patients
in whom operation will be delayed, endoscopic
biliary stenting with a plastic stent or short metal
stent is currently the preferred modality for biliary decompression [4]. Finally, cardiopulmonary
risk stratification and management of medical
comorbidities is essential.
Arguably the single most important aspect of
successful PD is performing the pancreatic–enteric anastomosis. Pancreatic leak is the major
component of morbidity and mortality in every
series and is often referred to as the “Achilles
heel” of PD. The definitions and classification
of postoperative pancreatic fistula/anastomotic
leakage has been established by an international
consensus conference as an abnormal communication between the pancreatic ductal epithelium and another epithelial surface containing
pancreas-derived, enzyme-rich fluid. The clinical
criterion is output via an operatively placed drain
(or a subsequently placed, percutaneous drain) of
any measurable volume of fluid on or after postoperative day 3, with an amylase content greater
T. M. Pawlik et al. (eds.), Gastrointestinal Surgery, DOI 10.1007/978-1-4939-2223-9_27,
© Springer Science+Business Media New York 2015
281

282 J. C. King et al.
Table 27.1 International study group on pancreatic fistula ( ISGPF) classification. (Modified from [5])
ISGPF parameters for postoperative pancreatic fistula grading
Grade A B C
Clinical condition Well Often well Ill-appearing/bad
Specific treatment
US/CT (if obtained) Negative Negative/positive Positive
Persistent drainage (after 3 weeks)
Re-operation No No Ye s
Death related to POPF No No Possibly yes
Signs of infection No Ye s Yes
Sepsis No No Ye s
Re-admission No Yes/no Yes/no
US ultrasound, CT computed tomography, POPF postoperative pancreatic fistula. ISGPF International Study Group
on Pancreatic Fistula definition
a
Partial (peripheral) or total parenteral nutrition, antibiotics, enteral nutrition, somatostatin analogue, and/or minimal
invasive drainage
b
With or without a drain in situ;
a
No Yes/no Ye s
b
No Usually yes Yes
than three times the upper normal serum value
[5]. By definition anastomotic leakage requiring
re-operation is classified as grade C and is the
topic of discussion for this chapter (Table 27.1).
Given the fragile nature of the pancreatic
anastomosis and its propensity to leak, many
variations have been described with various advantages and disadvantages touted for each. Despite numerous studies comparing the type and
style of anastomosis (pancreaticojejunostomy
vs. pancreaticogastrostomy, [6–9] duct-to-mucosa vs. invagination technique, [10] pancreatic
duct stent vs. no stent [11–13], the choice for
management of the distal pancreatic remnant is
still largely a matter of surgeon preference and
comfort. The authors prefer a modified Blumgart
two-layer pancreaticojejunostomy with an outer
layer of 2-0 silk horizontal mattress sutures and
an inner duct-to-mucosa layer of 5-0 polydioxanone (PDS) performed end-to-side. However,
in an experienced pancreaticobiliary surgeon’s
hands, several approaches may have similar outcomes.
Anastomosis begins by dissecting 2–3 cm
of the pancreatic stump from surrounding tissues (Fig. 27.1a–c). The jejunal limb is brought
through the duodenal hiatus or another retrocolic window is made in the transverse colon
mesentery and positioned to allow creation of
a tension-free end-to-side anastomosis. Interrupted horizontal mattress sutures of 2-0 silk are
placed using transpancreatic bites of pancreas
and seromuscular bites of jejunum (Fig. 27.1a).
The needles are left on these sutures and used for
the anterior seromuscular buttressing layer later.
Care must be taken not to suture the pancreatic
duct; thus, a temporary 5F or 7F Hobbs ERCP
stent (Hobbs Medical, Stafford Springs, CT) is
placed in the duct to help prevent inadvertent
occlusion. Three sutures are required for the
posterior row: one superior, one straddling the
pancreatic duct, and one inferiorly. The middle
stitch is placed while moving the stent in the duct
to assure the knot is not tied too tight. Next, a
2–3 mm enterotomy is made in the jejunum, and
the inner suture line is constructed with interrupted 5-0 PDS. Beginning at the superior aspect
of the gland, the suture line incorporates the pancreatic duct and full-thickness jejunum. Depending on the size of the duct, it is usually possible
to place three to five sutures in a duct-to-mucosa
fashion in the anterior and posterior rows, each.
After the posterior suture line is complete, it is
tied down and the Hobbs stent is inserted into
the pancreatic duct with the curved end inserted
into the jejunum (Fig. 27.1b). The anterior suture
line is formed. Finally, the anterior row of 3-0
silk mattress sutures are placed using seromuscular bites of jejunum secured to the capsule of
the pancreas. In tying the sutures, take extreme
care to avoid pulling the sutures through the tissue when attempting to imbricate the jejunum
over the anastomosis, particularly when the pancreas is soft (Fig. 27.1c). A #19 round channel

28327 Major Disruptions of Pancreaticojejunostomy
Fig. 27.1 a Completed posterior row of 3-0 silk stitches. b Posterior row of 5-0 PDS duct-to-mucosa stitches and pan-
creatic duct stent in place. c Completed pancreaticojejunostomy
drain is placed in the region of the anastomosis
to help detect leakage and manage smaller leaks
in the postoperative period. Although not classically described in the literature, in the opinion of
the authors, attention should also be paid to the
placement of the biliary anastomosis with respect
to the pancreatic anastomosis. Whenever possible, at least 10–15 cm should be left between
the two anastomoses to prevent reflux of biliary
fluid into the pancreatic anastomosis. Although
little clinical evidence exists to support this practice, it is an important anecdotal observation that
may decrease the incidence of massive pancreatic anastomotic disruption.
There exists some debate on the use of closed
suction drains following PD. Drainage of the
pancreatic anastomosis may be associated with
greater likelihood of pancreatic fistula, and some
have advocated abandoning the use of drains
routinely following PD [14, 15]. It is the opinion
of the authors that drains should be placed following most, if not all PD and clinical trials support this. A recent randomized multicenter trial
comparing routine placement of operative drains
to no drains following PD provides level-one
evidence that routine use of closed suction drains
should be standard of care. In this study, all-cause
mortality was higher in the no drain group and
there was an increased number and mean severity
of complications when operative drains were not
placed. There was no increase in the incidence of
pancreatic fistula between the two groups [16].
It is likely that the excess mortality seen in the
no drain group reflects the consequences of undrained pancreatic fluid in the small number of patients who develop significant compromise to the
integrity of the pancreaticojejunostomy, resulting
in the development of multisystem organ failure
(MSOF) and death.
Despite compelling data supporting the routine use of drains, an emerging consensus also
suggests that they represent a double-edged
sword and can lead to an increased incidence of
pancreatic fistula when left in situ for a prolonged
period of time. Prospective data indicate that amylase activity of drain effluent less than 5000 U/L
predicts a low likelihood of clinically significant
pancreatic fistula [17]. In these patients with
a low risk of pancreatic fistula, drains may be
safely removed early in the postoperative period
without relying on standard metrics of drainage
character or volume. A prospective randomized
study investigating early removal of operative
closed suction drains in patients with postoperative day 1 drain that amylase values of less than
5000 U/L found significantly fewer complications, including pancreatic fistulae in the early
removal group (postoperative day (POD) 3 vs. ≥
POD 5) [18]. Several caveats should be noted in
this study including the fact that the authors did
not use closed suction drains and subjects were
only randomized if they showed “no adverse
clinical metrics.”
It is the author’s opinion that closed suction
drains are important in the early postoperative
period to assist in management of major disruptions of the pancreatic anastomosis. However,
persistent application of negative pressure can
clearly lead to persistence of a “nuisance” lowgrade fistula. Since 2008, we have adopted a
modified “Verona” protocol: One or two #19
channeled closed suction drains are placed near
the pancreatic anastomosis and drain amylase activity is measured on POD 3. For patients who

284 J. C. King et al.
are clinically improving and have drain amylase
activity of less than two to three times the serum
amylase on POD 4, the drain(s) is/are removed.
In our experience, this approach has resulted in
a very low rate of uncontrolled pancreatic leaks
while also minimizing clinically insignificant
“nuisance” low-grade fistulae.
Major anastomotic disruptions typically present early in the postoperative course (POD 3–5)
though they may occur later, as in the case of an
operative drain that has eroded tissues, thus creating an anastomotic dehiscence. Often, the first
recognized indications of a major disruption of
the pancreatic anastomosis will be deteriorating
clinical indices such as tachycardia, hypotension, fever, and oliguria. Delayed return of bowel
function and/or delayed gastric emptying is also
common, though nonspecific findings. Leukocytosis/leucopenia, electrolyte abnormalities (i.e.,
acidemia, hypokalemia), thrombocytopenia/
thrombocytosis, coagulopathy, and anemia are
frequent laboratory findings. In cases of grade
C fistula, patients may meet criteria for systemic
inflammatory response syndrome (SIRS)/sepsis
and many experience some degree of MSOF involving cardiac, respiratory, renal, hepatic, and
other organ systems.
Management of major pancreatic anastomotic
disruption should progress in a logical, stepwise
fashion (Fig. 27.2). The two primary clinical
goals in the early setting of a massive pancreatic anastomotic failure are goal-directed resuscitation to maintain end-organ perfusion and
establishment of a controlled pancreatic fistula.
Intravenous fluids (either crystalloid or blood,
as indicated) to maintain euvolemia and correct
acidosis should be administered. Adequate vascular access including central venous catheter(s),
arterial catheter, and/or pulmonary artery catheter may be indicated.
In attempting to diagnose and characterize
pancreatic fistulae, computed tomography (CT)
scans of the abdomen have limited ability to assess the integrity of the pancreatic anastomosis
and are only used to assess for the presence of undrained pancreatic fluid collections (Fig. 27.3).
Patients are often acutely ill, and the decision
of whether and when to transport to the radiol-
ogy department should be carefully considered.
Given that most patients with significant SIRS
have disruptions in regional blood flow to the
kidney and are at significant risk of contrastinduced nephropathy, intravenous (IV) contrast
should rarely be used.
An attempt at nonoperative management is
warranted and is successful in a vast majority of
instances in the experience of the authors. For situations where a surgical drain was not placed, the
patient demonstrates clinical SIRS, and a major
pancreatic anastomotic disruption is suspected,
an attempt at image-guided percutaneous drainage is worthwhile in all but the most unstable patients. Most patients will demonstrate significant
and rapid clinical improvement with successful
establishment of a controlled fistula via a percutaneous drain. In patients with existing surgically
placed drains, a noncontrast CT scan can be considered to rule out displacement of the drain and/
or presence of undrained collections.
Once drainage is accomplished, the character
of the drain fluid should be noted: Classically,
thin, cloudy, gray “dishwater” fluid is observed
in situations of major disruptions. It is important
to note that drain fluid from major pancreaticojejunostomy disruptions is often bilious. Bile may
leak retrograde from the hepaticojejunostomy
through a disruption in the pancreaticojejunostomy if it is not draining antegrade through the
efferent jejunal limb. Considering that the hepaticojejunostomy is a more structurally robust
anastomosis, bilious drainage can be considered
the more likely result of a leaking pancreaticojejunostomy than vice versa. As was noted above
in the section on constructing a pancreaticojejunostomy, this bile reflux may be more significant
when there is insufficient length between the hepaticojejunostomy and pancreaticojejunostomy
and, in the opinion of the authors, contributes to
development of severe pancreatic fistulae.
Bloody drainage is a particularly ominous sign
as this may indicate hemorrhage from a ruptured
pseudoaneurysm of the gastroduodenal artery or
other visceral arterial branches exposed during
the course of dissection. Most cases of pseudoaneurysm rupture appear later in the course of a
significant pancreatic leak, often 2–3 days after

28527 Major Disruptions of Pancreaticojejunostomy
Fig. 27.2 Diagnostic/therapeutic algorithm for pancreati-
cojejunostomy dehiscence. Single asterisk drain output:
bilious, “cloudy/dishwater”, bloody; double asterisk clinical indices: tachycardia, fever, leukocytosis, abdominal
recognition of the leak when the patient has recovered from the initial insult. As with pancreatic
fistula, an international study group classification
of postpancreatectomy bleeding has been established (Table 27.2, 27.3) [19].
Empiric broad-spectrum antibiotics are often
indicated and should cover Gram-negative
( Escherichia coli, Klebsiella pneumoniae, En-
pain; PD pancreaticoduodenectomy, PF pancreatic fistula, SIRS systemic inflammatory response syndrome,
MSOF multisystem organ failure
terobacter), enteric Gram-positive ( Enterococcus), and possibly fungal ( Candida) organisms.
Bile cultures obtained at the time of index operation have been advocated as helpful in this scenario, particularly if preoperative biliary stenting
was performed.
The decision to re-operate is based on the presence of refractory and progressively worsening
Соседние файлы в папке Библиотека им академика М.И. Перельмана
